Literature DB >> 24374606

Assessing sinus aerosol deposition: benefits of SPECT-CT imaging.

Lara Leclerc1, Jérémie Pourchez2, Nathalie Prevot3, Laurent Vecellio4, Sandrine Le Guellec4, Michèle Cottier5, Marc Durand6.   

Abstract

PURPOSE: Aerosol inhalation therapy is one of the methods to treat rhinosinusitis. However the topical drug delivery to the posterior nose and paranasal sinuses shows only limited efficiency. A precise sinusal targeting remains a main challenge for aerosol treatment of sinus disorders. This paper proposes a comparative study of the nasal deposition patterns of micron and submicron particles using planar gamma-scintigraphy imaging vs. a new 3-dimensional (3D) imaging approach based on SPECT-CT measurements.
METHODS: Radiolabelled nebulizations have been performed on a plastinated model of human nasal cast coupled with a respiratory pump. First, the benefits provided by SPECT-CT imaging were compared with 2D gamma-scintigraphy and radioactive quantification of maxillary sinus lavage as reference for the sonic 2.8 μm aerosol sinusal deposition. Then, the impact on nasal deposition of various airborne particle sizes was assessed.
RESULTS: The 2D methodology overestimates aerosol deposition in the maxillary sinuses by a factor 9 whereas the 3D methodology is in agreement with the maxillary sinus lavage reference methodology. Then with the SPECT-CT approach we highlighted that the higher particle size was mainly deposited in the central nasal cavity contrary to the submicron aerosol particles (33.8 ± 0.6% of total deposition for the 2.8 μm particles vs. 1 ± 0.3% for the 230 nm particles).
CONCLUSION: Benefits of SPECT/CT for the assessment of radiolabelled aerosol deposition in rhinology are clearly demonstrated. This 3D methodology should be preferentially used for scintigraphic imaging of sinusal deposition in Human.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aerosol deposition; Aerosol therapy; SPECT/CT imaging

Mesh:

Substances:

Year:  2013        PMID: 24374606     DOI: 10.1016/j.ijpharm.2013.12.032

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  7 in total

1.  A new Strategy to Improve Drug Delivery to the Maxillary Sinuses: The Frequency Sweep Acoustic Airflow.

Authors:  Amira El Merhie; Laurent Navarro; Xavier Delavenne; Lara Leclerc; Jérémie Pourchez
Journal:  Pharm Res       Date:  2015-12-30       Impact factor: 4.200

Review 2.  Image-Guided Drug Delivery with Single-Photon Emission Computed Tomography: A Review of Literature.

Authors:  Rubel Chakravarty; Hao Hong; Weibo Cai
Journal:  Curr Drug Targets       Date:  2015       Impact factor: 3.465

3.  Impact of airborne particle size, acoustic airflow and breathing pattern on delivery of nebulized antibiotic into the maxillary sinuses using a realistic human nasal replica.

Authors:  Lara Leclerc; Jérémie Pourchez; Gérald Aubert; Sandrine Leguellec; Laurent Vecellio; Michèle Cottier; Marc Durand
Journal:  Pharm Res       Date:  2014-03-04       Impact factor: 4.200

4.  Development of an ex vivo human-porcine respiratory model for preclinical studies.

Authors:  Sophie Perinel; Jérémie Pourchez; Lara Leclerc; John Avet; Marc Durand; Nathalie Prévôt; Michèle Cottier; Jean M Vergnon
Journal:  Sci Rep       Date:  2017-02-24       Impact factor: 4.379

5.  In vitro qualitative and quantitative CT assessment of iodinated aerosol nasal deposition using a 3D-printed nasal replica.

Authors:  Thomas Sartoretti; Manoj Mannil; Stefan Biendl; Johannes M Froehlich; Hatem Alkadhi; Matthias Zadory
Journal:  Eur Radiol Exp       Date:  2019-08-21

6.  Micron-sized and submicron-sized aerosol deposition in a new ex vivo preclinical model.

Authors:  Sophie Perinel; Lara Leclerc; Nathalie Prévôt; Agathe Deville; Michèle Cottier; Marc Durand; Jean-Michel Vergnon; Jérémie Pourchez
Journal:  Respir Res       Date:  2016-07-07

7.  Characterization of aerosols containing Legionella generated upon nebulization.

Authors:  Séverine Allegra; Lara Leclerc; Pierre André Massard; Françoise Girardot; Serge Riffard; Jérémie Pourchez
Journal:  Sci Rep       Date:  2016-09-27       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.